LobbyingNeogenomics Laboratories lobbying by quarter
Neogenomics Laboratories's latest lobbying report covers Q4 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs and Budget/Appropriations.
Neogenomics Laboratories
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 2 |
| Q1 2023 | $20K | 2 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$25K · 2 reports
- Veterans$25K · 2 reports
- Medical research and clinical labs$0 · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Cassidy & Associates | $50K | 2 quarters |
| In-houseNeogenomics Laboratories | $0 | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLES SYDNOR | Rep. Wilson- legislative assistant/counsel; Senator Boozman- legislative assistant/counsel; Senator Burr- legislative assistant/counsel | Q4 2022 |
| MICHELLE GREENE | Ch Ch, Cong Affairs, OTSG; Army Lia FM&C; DepSurgGen,OTSG; Dep CH, Pt Adm, Tripler AMC; Pt Adm, Clin Ops, NARMC; Co Cdr, Walter Reed; Dep Ch, Pt Adm, Winn Hosp | Q4 2022 |
| SARAH YOUNG GLACKIN | Professional Staff Member for the House Appropriations Committee, Subcommittees on Defense, Interior, Military Quality of Life and Military Construction and VA | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/01/22for Q4 2024 | In-house | Under $5,000 |
| 25/01/16for Q4 2024 | In-house | Under $5,000 |
| 24/10/04for Q3 2024 | In-house | Under $5,000 |
| 24/07/24for Q2 2024 | In-house | Under $5,000 |
| 24/04/22for Q1 2024 | In-house | Under $5,000 |
| 24/01/17for Q4 2023 | In-house | Under $5,000 |
| 23/10/19for Q3 2023 | In-house | Under $5,000 |
| 23/07/19for Q2 2023 | In-house | Under $5,000 |
| 23/04/27for Q1 2023 | In-house | Under $5,000 |
| 23/04/18for Q1 2023 | Cassidy & Associates | $20K |
| 23/01/22for Q4 2022 | In-house | Under $5,000 |
| 23/01/12for Q4 2022 | Cassidy & Associates | $30K |